NAD+

Nicotinamide adenine dinucleotide

NAD+ is in every cell in your body and it declines about 50% between ages 40 and 60. The pitch: restore NAD+ levels, restore cellular function. The reality: systematic reviews keep finding insufficient evidence that injecting it beats oral precursors. NMN and NR capsules actually absorb better than people expect, at a fraction of the cost. IV clinics charge $200-600 per session, SubQ runs $150-400/month, and the evidence that either beats a $30 bottle of NMN isn't there yet. Start with oral before spending clinic money.

Protocol

Dose: IV: 250-500mg per session. SubQ: 50-200mg per injection. Oral (NMN/NR): 250-1000mg daily. | Frequency: IV: 1-2x per week for loading, then monthly. SubQ: 2-3x per week. Oral: daily. | Cycle: No standard cycling. Most people run continuous with oral precursors. | Route: IV (clinic), SubQ (home), Oral (NMN/NR supplements)

Reconstitution: SubQ: Follow vial-specific instructions. IV: Clinical administration only.. Use our free reconstitution calculator for exact syringe units.

Effects

Side Effects

Evidence

Early research — A 2024 systematic review found zero eligible human trials evaluating injectable NAD+ for anti-aging or wellness outcomes. Oral precursors (NMN, NR) have some RCT data showing elevated blood NAD+ levels, but clinically relevant outcomes weren't significantly different from placebo. The theoretical advantage of injection over oral hasn't been established. This is the most overhyped molecule in the longevity space relative to its actual evidence base.

Approval status: Not approved as injectable therapeutic. NMN/NR sold as supplements.

References

  1. Verdin E et al. NAD+ in aging, metabolism, and neurodegeneration Science, 2015. PMID: 26785480
  2. Gallagher C et al. NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence Ageing Res Rev, 2026. PMID: 41655607
  3. Yi L et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial GeroScience, 2023. PMID: 36482258
  4. Yamaguchi S et al. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men Endocr J, 2024. PMID: 38191197
  5. Radenkovic D et al. Clinical Evidence for Targeting NAD Therapeutically Pharmaceuticals (Basel), 2020. PMID: 32942582
  6. Dellinger RW et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study NPJ Aging Mech Dis, 2017. PMID: 29184669

Storage

← Browse all peptides | Dose calculator →

These statements have not been evaluated by the FDA. This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any protocol.

vialprep research · Sources: PubMed, FDA, peer-reviewed trials · How we verify